MGNX Archived Articles
MacroGenics Inc. (MGNX): A Resilient Biopharmaceutical Player Navigating the Evolving Oncology Landscape
Published on March 15, 2025
MacroGenics: A Biotech Powerhouse Navigating the Complexities of Cancer Treatment
Published on November 26, 2024
MacroGenics, Inc. (NASDAQ:MGNX) Promising Pipeline and Improved Safety Profile for Lead ADC Candidate
Published on September 24, 2024